Launch Price and Access Report: Drug Approvals from 2023-2024
ICER will conduct a new analysis it plans to release on an annual basis titled the “Launch Price and Access Report” which will examine launch pricing for FDA-approved treatments. This report will review the affordability and access of the treatments and their value to the overall health system. ICER will examine all novel drug approvals […]